Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Current Gastroenterology Reports|April 23, 2013
Chemoprevention of gastrointestinal neoplasiaElizabeth Half, Nadir ArberExpert Opinion on Pharmacotherapy|February 25, 2009
Colon cancer: preventive agents and the present status of chemopreventionElizabeth Half, Nadir ArberOrphanet Journal of Rare Diseases|October 14, 2009
Familial adenomatous polyposisElizabeth Half, Dani Bercovich, Paul RozenCancer Letters|December 27, 2006
Anti-EGFR and ErbB-2 antibodies attenuate cyclooxygenase-2 expression and cooperatively inhibit survival of human colon cancer cellsElizabeth Half, Yunjie Sun, Frank A SinicropeHarefuah|March 3, 2024
[FRONTIERS IN CANCER PREDICTION AND EARLY DETECTION]Amit Shalel, Fares Mazawi, Lana Kupershmidt, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|May 12, 2016
Guaiac faecal occult blood screening in individuals younger than 50 years of ageRonen Zalts, Zeid Moadi, Ophir Avizohar, et al.Cancer Research|September 5, 2002
Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cellsXiming Tang, Yun Jie Sun, Elizabeth Half, et al.Cancer Research|November 5, 2002
Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cellsYunjie Sun, Xi Ming Tang, Elizabeth Half, et al.Rambam Maimonides Medical Journal|October 13, 2018
Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center ExperienceJesse Lachter, Carly Rosenberg, Tomer Hananiya, et al.Cancer Research|March 26, 2002
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situElizabeth Half, Xi Ming Tang, Karin Gwyn, et al.Pageof 4